Cormorant Asset Management, LP Insider Trading Activity

Also formerly known as Cormorant Asset Management, LLC
Average Profitability
<0.0001%
Insider Buys Quantity
28
Insider Buys Sum
$327.07M
Insider Sells Quantity
3
Insider Sells Sum
$3.91M

Insider Activity of Cormorant Asset Management, LP

According to the SEC Form 4 filings, Cormorant Asset Management, LP, being in a position of

  1. Former 10% Owner at Bright Minds Biosciences Inc.,
    оver the last 12 months, has bought 0 shares, and sold 109331 share for $9.79M,
    over all time since 2024-10-15, has bought 606922 shares for $7.23M, and sold 109331 share for $9.79M.

Biography of Cormorant Asset Management, LP

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $12,814,1324100

Comparison of Insiders on Amount of Buys and Sells

2026-10-29SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Former 10% Owner
425,000
2.1279%
$4.10$1.74M-7.23%
2026-04-28SaleBright Minds Biosciences Inc.
DRUG
Former 10% Owner
109,331
1.4167%
$89.50$9.79M-20.4%
2025-12-11SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
10 percent owner
30,029
0.2829%
$11.46$344,012-11.16%
2025-12-04SaleEyePoint Pharmaceuticals, Inc.
EYPT
Former 10% Owner
60,000
0.0821%
$15.70$942,240-20.51%
2025-05-15SaleOnKure Therapeutics, Inc.
OKUR
Former 10% Owner
1.81M
8.5595%
$1.85$3.36M+37.38%
2025-05-12SaleOnKure Therapeutics, Inc.
OKUR
10 percent owner
24,300
0.1228%
$1.99$48,236+44.62%
2024-11-04PurchaseBright Minds Biosciences Inc.
DRUG
10 percent owner
184,331
1.3083%
$21.70$4M-28.71%
2024-10-16PurchaseBright Minds Biosciences Inc.
DRUG
10 percent owner
50,000
0.3836%
$23.46$1.17M+25.14%
2024-10-15PurchaseBright Minds Biosciences Inc.
DRUG
10 percent owner
372,591
0.6743%
$5.53$2.06M-6.46%
2024-09-20PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
10 percent owner
350,000
3.227%
$20.01$7M-52.49%
2024-05-06PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
850,000
1.8064%
$11.86$10.08M-25.18%
2024-04-18PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
581,765
1.2029%
$18.03$10.49M-50.63%
2024-04-01SaleImmuneering Corporation
IMRX
10 percent owner
400,000
1.4407%
$2.90$1.16M-38.55%
2024-03-15SaleImmuneering Corporation
IMRX
10 percent owner
400,000
1.5312%
$2.14$856,400-5.76%
2024-03-14SaleImmuneering Corporation
IMRX
10 percent owner
509,091
1.0954%
$3.72$1.89M-37.93%
2024-03-08PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
10 percent owner
300,000
6.1345%
$44.38$13.31M-17.56%
2024-03-07PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
10 percent owner
250,000
4.6136%
$40.05$10.01M-7.99%
2024-02-02PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
10 percent owner
750,000
6.5656%
$19.00$14.25M+39.41%
2024-01-26PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
10 percent owner
282,632
4.1983%
$32.24$9.11M+26.31%
2024-01-11PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
750,000
2.0594%
$19.75$14.81M-51.69%
Total: 32
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.